search
Back to results

Optimal Time for Follow up After Variceal Band Ligation

Primary Purpose

Esophageal Varices

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Esophageal Variceal Band ligation
Sponsored by
Tanta University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Esophageal Varices

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • cirrhotic portal hypertension with medium or large sized or risky varices or variceal bleeding

Exclusion Criteria:

  • non-cirrhotic portal hypertension

Sites / Locations

  • Sherief Abd-ElsalamRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

follow up every week

follow up every 2 weeks

follow up every 3 weeks

follow up every 4 weeks

Arm Description

Variceal Band ligation every week.

Variceal Band ligation every 2 weeks

Variceal Band ligation every 3 weeks

Variceal Band ligation every 4 weeks

Outcomes

Primary Outcome Measures

Number of patients with eradicated varices
The total number of patients with eradicated varices

Secondary Outcome Measures

Full Information

First Posted
October 20, 2020
Last Updated
October 20, 2020
Sponsor
Tanta University
search

1. Study Identification

Unique Protocol Identification Number
NCT04602663
Brief Title
Optimal Time for Follow up After Variceal Band Ligation
Official Title
Optimal Time for Follow up After Variceal Band Ligation in Cirrhotic Patients: a Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
December 1, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tanta University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Optimal time for follow up after variceal band ligation in cirrhotic patients remains to be determined
Detailed Description
Optimal time for follow up after variceal band ligation in cirrhotic patients remains to be determined. So, we designed this trial to answer this question.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Varices

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
follow up every week
Arm Type
Experimental
Arm Description
Variceal Band ligation every week.
Arm Title
follow up every 2 weeks
Arm Type
Experimental
Arm Description
Variceal Band ligation every 2 weeks
Arm Title
follow up every 3 weeks
Arm Type
Experimental
Arm Description
Variceal Band ligation every 3 weeks
Arm Title
follow up every 4 weeks
Arm Type
Experimental
Arm Description
Variceal Band ligation every 4 weeks
Intervention Type
Device
Intervention Name(s)
Esophageal Variceal Band ligation
Other Intervention Name(s)
Band ligation
Intervention Description
Band ligation of OV
Primary Outcome Measure Information:
Title
Number of patients with eradicated varices
Description
The total number of patients with eradicated varices
Time Frame
1 year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: cirrhotic portal hypertension with medium or large sized or risky varices or variceal bleeding Exclusion Criteria: non-cirrhotic portal hypertension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sherief Abd-Elsalam, MD
Phone
00201147773440
Email
sheriefabdelsalam@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
Mohamed Alboraie, MD
Phone
0020106445739
Email
sheriefabdelsalam@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohamed Alboraie, MD
Organizational Affiliation
Al-Azhar University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ahmed Maher, MD
Organizational Affiliation
Cairo University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sherief Abd-Elsalam
City
Tanta
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sherief Abd-elsalam, lecturer
Phone
00201000040794
Email
Sherif_tropical@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Optimal Time for Follow up After Variceal Band Ligation

We'll reach out to this number within 24 hrs